| Literature DB >> 28652253 |
Eunae You1, Yun Hyun Huh2, Ahreum Kwon2, So Hee Kim2, In Hee Chae2, Ok-Jun Lee3, Je-Hwang Ryu4, Min Ho Park5, Ga-Eon Kim6, Ji Shin Lee6, Kun Ho Lee7, Yong-Seok Lee1, Jung-Woong Kim1, Sangmyung Rhee8, Woo Keun Song9.
Abstract
Biomechanical remodeling of stroma by cancer-associated fibroblasts (CAF) in early stages of cancer is critical for cancer progression, and mechanical cues such as extracellular matrix stiffness control cell differentiation and malignant progression. However, the mechanism by which CAF activation occurs in low stiffness stroma in early stages of cancer is unclear. Here, we investigated the molecular mechanism underlying CAF regulation by SPIN90 and microtubule acetylation under conditions of mechanically soft matrices corresponding to normal stromal rigidity. SPIN90 was downregulated in breast cancer stroma but not tumor, and this low stromal expression correlated with decreased survival in breast cancer patients. Spin90 deficiency facilitated recruitment of mDia2 and APC complex to microtubules, resulting in increased microtubule acetylation. This increased acetylation promoted nuclear localization of YAP, which upregulated expression of myofibroblast marker genes on soft matrices. Spin90 depletion enhanced tumor progression, and blockade of microtubule acetylation in CAF significantly inhibited tumor growth in mice. Together, our data demonstrate that loss of SPIN90-mediated microtubule acetylation is a key step in CAF activation in low stiffness stroma. Moreover, correlation among these factors in human breast cancer tissue supports the clinical relevance of SPIN90 and microtubule acetylation in tumor development. Cancer Res; 77(17); 4710-22. ©2017 AACR. ©2017 American Association for Cancer Research.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28652253 DOI: 10.1158/0008-5472.CAN-17-0657
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 12.701